Protagenic Therapeutics, Inc.\new (PTIX) Income towards Parent Company (2013 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) posted Income towards Parent Company of -$963,616 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$5.06 million a year earlier.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Income towards Parent Company (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Protagenic Therapeutics, Inc.\new was $5.46 million; for FY2026 (ended Mar 31, 2026), it came in at $1.37 million.
- In prior fiscal years, Protagenic Therapeutics, Inc.\new's Income towards Parent Company was -$3.59 million in FY2025, -$5.53 million in FY2024, -$5 million in FY2023 and -$3.56 million in FY2022.
- Quarterly Income towards Parent Company has run from a low of -$5.06 million in fiscal Q1 2026 to a high of $5.08 million in fiscal Q4 2026 over five years.
- According to Business Quant data, Income towards Parent Company for the three prior fiscal quarters was $5.08 million (Q4 2026), $2.21 million (Q3 2026) and -$869,496 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.30 Mn | 1.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -963,616.00 |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | -869,496.00 |
| Jun 30, 2025 | -5.06 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | -850,287.00 |
| Sep 30, 2024 | -582,387.00 |
| Jun 30, 2024 | -324,355.00 |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -1.68 Mn |
| Sep 30, 2023 | -1.40 Mn |
| Jun 30, 2023 | -1.21 Mn |
| Mar 31, 2023 | -718,096.00 |
| Dec 31, 2022 | -601,374.00 |
| Sep 30, 2022 | -925,305.00 |
| Jun 30, 2022 | -666,717.00 |
| Mar 31, 2022 | -1.36 Mn |
| Dec 31, 2021 | -890,387.00 |
| Sep 30, 2021 | -878,299.00 |
API Access
Protagenic Therapeutics, Inc.\new Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();